tradingkey.logo
tradingkey.logo
Pesquisar

Fortrea Holdings Inc

FTRE
Adicionar à lista de desejos
13.660USD
-0.580-4.07%
Fechamento 05/15, 16:00ETCotações atrasadas em 15 min
1.29BValor de mercado
PerdaP/L TTM

Mais detalhes de Fortrea Holdings Inc Empresa

Fortrea Holdings Inc. is a global contract research organization (CRO), which provides clinical development solutions to the life sciences industry. The Company is engaged in providing biopharmaceutical product and medical device development services to pharmaceutical, biotechnology and medical device customers. The Company offers customers flexible delivery models that include full service, functional service provider, and hybrid service structures. It provides phase I-IV clinical trial management, clinical pharmacology and consulting services. The Company manages its business through a single segment, Clinical Services, that provides services across the clinical pharmacology and clinical development spectrum. The Company has access to all key markets worldwide through a footprint of primary office locations in five countries (the United States, the United Kingdom, China, India and Singapore) with field operations in other jurisdictions worldwide.

Informações de Fortrea Holdings Inc

Código da empresaFTRE
Nome da EmpresaFortrea Holdings Inc
Data de listagemJun 16, 2023
CEOThakrala (Anshul)
Número de funcionários15500
Tipo de títulosOrdinary Share
Fim do ano fiscalJun 16
Endereço8 Moore Drive
CidadeDURHAM
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal27709
Telefone18774950816
Sitehttps://www.fortrea.com/
Código da empresaFTRE
Data de listagemJun 16, 2023
CEOThakrala (Anshul)

Executivos da empresa Fortrea Holdings Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Peter M. Neupert
Mr. Peter M. Neupert
Chairman of the Board
Chairman of the Board
98.13K
--
Dr. Amrit Ray, M.D.
Dr. Amrit Ray, M.D.
Lead Independent Director
Lead Independent Director
52.45K
+74.00%
Mr. Edward A. Pesicka
Mr. Edward A. Pesicka
Independent Director
Independent Director
52.45K
+74.00%
Mr. David Ross Smith
Mr. David Ross Smith
Independent Director
Independent Director
48.36K
+80.27%
Ms. Machelle Sanders
Ms. Machelle Sanders
Independent Director
Independent Director
46.10K
+84.20%
Ms. Jill Mcconnell
Ms. Jill Mcconnell
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Mark Morais
Mr. Mark Morais
Chief Operating Officer and President - Clinical Services
Chief Operating Officer and President - Clinical Services
--
--
Ms. Hima B. Inguva
Ms. Hima B. Inguva
Investor Relations
Investor Relations
--
--
Ms. Erin L. Russell
Ms. Erin L. Russell
Independent Director
Independent Director
--
--
Mr. Anshul Thakrala
Mr. Anshul Thakrala
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Peter M. Neupert
Mr. Peter M. Neupert
Chairman of the Board
Chairman of the Board
98.13K
--
Dr. Amrit Ray, M.D.
Dr. Amrit Ray, M.D.
Lead Independent Director
Lead Independent Director
52.45K
+74.00%
Mr. Edward A. Pesicka
Mr. Edward A. Pesicka
Independent Director
Independent Director
52.45K
+74.00%
Mr. David Ross Smith
Mr. David Ross Smith
Independent Director
Independent Director
48.36K
+80.27%
Ms. Machelle Sanders
Ms. Machelle Sanders
Independent Director
Independent Director
46.10K
+84.20%
Ms. Jill Mcconnell
Ms. Jill Mcconnell
Chief Financial Officer
Chief Financial Officer
--
--

Detalhamento da receita

Moeda: USDAtualizado em: seg, 6 de abr
Moeda: USDAtualizado em: seg, 6 de abr
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q3
FY2022Q2
FY2021
FY2020
Os dados relevantes ainda não foram divulgados pela empresa.
Por RegiãoUSD
Nome
Receita
Proporção
North America
1.29B
47.35%
Europe
851.70M
31.27%
Other
582.10M
21.37%
Por Empresa
Por Região
Os dados relevantes ainda não foram divulgados pela empresa.

Distribuição de ações

Atualizado em: dom, 10 de mai
Atualizado em: dom, 10 de mai
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
BlackRock Institutional Trust Company, N.A.
13.95%
Goldman Sachs & Company, Inc.
8.39%
Corvex Management LP
4.77%
State Street Investment Management (US)
4.35%
Vanguard Capital Management, LLC
4.27%
Outro
64.27%
Investidores
Investidores
Proporção
BlackRock Institutional Trust Company, N.A.
13.95%
Goldman Sachs & Company, Inc.
8.39%
Corvex Management LP
4.77%
State Street Investment Management (US)
4.35%
Vanguard Capital Management, LLC
4.27%
Outro
64.27%
Tipos de investidores
Investidores
Proporção
Investment Advisor
45.75%
Hedge Fund
22.47%
Investment Advisor/Hedge Fund
20.28%
Research Firm
12.48%
Pension Fund
1.58%
Bank and Trust
1.55%
Individual Investor
0.61%
Family Office
0.34%
Holding Company
0.05%

Participação acionária institucional

Atualizado em: qua, 1 de abr
Atualizado em: qua, 1 de abr
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2026Q1
881
98.32M
103.93%
-25.18M
2025Q4
861
101.77M
121.97%
--
2025Q3
941
101.78M
123.79%
-128.81K
2025Q2
971
101.91M
125.96%
+8.10M
2025Q1
934
96.29M
123.92%
-15.90M
2024Q4
888
96.88M
127.14%
-3.71M
2024Q3
843
100.39M
126.92%
-3.95M
2024Q2
819
103.77M
114.37%
+7.39M
2024Q1
774
92.63M
104.75%
-1.02M
2023Q4
713
91.56M
111.23%
-6.24M
Ver Mais

Atividade dos acionistas

Nome
Ações detidas
Proporção
Variação
Var. %
Data
BlackRock Institutional Trust Company, N.A.
13.20M
14.12%
+528.42K
+4.17%
Dec 31, 2025
Goldman Sachs & Company, Inc.
7.94M
8.49%
+48.14K
+0.61%
Dec 31, 2025
Corvex Management LP
4.51M
4.82%
--
--
Dec 31, 2025
State Street Investment Management (US)
4.11M
4.4%
+39.78K
+0.98%
Dec 31, 2025
Sessa Capital
3.99M
4.27%
--
--
Dec 31, 2025
Charles Schwab Investment Management, Inc.
3.22M
3.44%
+565.89K
+21.33%
Dec 31, 2025
AQR Capital Management, LLC
2.99M
3.2%
-747.42K
-20.01%
Dec 31, 2025
Fidelity Management & Research Company LLC
2.57M
2.75%
-395.60K
-13.34%
Dec 31, 2025
Ver Mais

ETFs Relacionados

Atualizado em: sáb, 6 de dez
Atualizado em: sáb, 6 de dez
Nome
Proporção
Brandes US Small-Mid Cap Value ETF
1.39%
Invesco S&P Spin-Off ETF
0.97%
Invesco S&P SmallCap Health Care ETF
0.58%
Invesco S&P SmallCap 600 Revenue ETF
0.25%
Invesco S&P SmallCap 600 Pure Value ETF
0.23%
Schwab Fundamental U.S. Small Company ETF
0.17%
iShares S&P Small-Cap 600 Value ETF
0.16%
Humankind US Stock ETF
0.14%
ProShares Ultra Nasdaq Biotechnology
0.14%
State Street SPDR S&P 600 Small Cap Value ETF
0.13%
Ver Mais
Brandes US Small-Mid Cap Value ETF
Proporção1.39%
Invesco S&P Spin-Off ETF
Proporção0.97%
Invesco S&P SmallCap Health Care ETF
Proporção0.58%
Invesco S&P SmallCap 600 Revenue ETF
Proporção0.25%
Invesco S&P SmallCap 600 Pure Value ETF
Proporção0.23%
Schwab Fundamental U.S. Small Company ETF
Proporção0.17%
iShares S&P Small-Cap 600 Value ETF
Proporção0.16%
Humankind US Stock ETF
Proporção0.14%
ProShares Ultra Nasdaq Biotechnology
Proporção0.14%
State Street SPDR S&P 600 Small Cap Value ETF
Proporção0.13%

Dividendo

Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados

Desdobramento de ações

Data
Data ex-dividendo
Tipo
Proporção
Sem dados
Data
Data ex-dividendo
Tipo
Proporção
Sem dados
KeyAI